MDPI and ACS Style
Rehues, P.; Girona, J.; Guardiola, M.; Plana, N.; Scicali, R.; Piro, S.; Muñiz-Grijalvo, O.; Díaz-Díaz, J.L.; Recasens, L.; Pinyol, M.;
et al. PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. Int. J. Mol. Sci. 2023, 24, 2319.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24032319
AMA Style
Rehues P, Girona J, Guardiola M, Plana N, Scicali R, Piro S, Muñiz-Grijalvo O, Díaz-Díaz JL, Recasens L, Pinyol M,
et al. PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. International Journal of Molecular Sciences. 2023; 24(3):2319.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24032319
Chicago/Turabian Style
Rehues, Pere, Josefa Girona, Montse Guardiola, Núria Plana, Roberto Scicali, Salvatore Piro, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Lluís Recasens, Marta Pinyol,
and et al. 2023. "PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk" International Journal of Molecular Sciences 24, no. 3: 2319.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24032319